In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.
The Centers for Medicare and Medicaid Services this week announced that they expect the average premium for a basic Medicare Part D prescription drug plan in 2016 to remain stable at about $32.50 per month.
The DEA announced on Tuesday that the 10th National Prescription Drug Take-Back will take place across the United States on Sept. 26 — except for in Pennsylvania and Delaware where the event will take place on Sept. 12.
The Consumer Healthcare Products Association expressed support for the DXM Abuse Prevention Act, introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson, R-Ohio, and Doris Matsui, D-Calif., on Wednesday.
Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.
The National Association of Chain Stores commented this week on the Centers for Medicare and Medicaid Services’ proposed regulations guiding the use of managed care in Medicaid and in the Children’s Health Insurance Program.